{
    "2021-08-12": [
        [
            {
                "time": "",
                "original_text": "康龙化成(03759.HK)投资康君仲元基金 初始认缴出资2.6亿元",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "康君仲元基金",
                        "初始认缴",
                        "出资2.6亿元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "北向资金交投趋谨慎全天净卖出不足2亿，贵州茅台连续11日遭抛售",
                "features": {
                    "keywords": [
                        "北向资金",
                        "谨慎",
                        "净卖出",
                        "贵州茅台",
                        "连续11日抛售"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "财信证券医药生物行业2021年8月月度报告：坚守高景气，关注高性价比个股",
                "features": {
                    "keywords": [
                        "财信证券",
                        "医药生物",
                        "高景气",
                        "高性价比个股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}